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The trophoblast cells are in direct contact with endometrial tissues throughout gestation, playing important early 
roles in implantation and placentation. The physiologic significance and the operating mechanisms involved in 
probable altered trophoblast functions following Chlamydia trachomatis infection were investigated to determine if 
C. trachomatis initiates productive infection in trophoblast, effects of such event on the biosynthesis of cholesterol 
and its derivatives estrogen and progesterone; and the regulator of the biosynthesis of these hormones, human 
chorionic gonadotropin. Chlamydia trachomatis exhibited productive infection in trophoblast typified by inclusion 
formation observed when chlamydia elementary bodies were harvested from trophoblast and titrated onto 
HEp-2 cells. Assessment of the status of C. trachomatis in trophoblast showed a relative increase in protein of 
HSP-60 compared with MOMP, features suggestive of chlamydial chronicity. There was a decrease in cellular 
cholesterol of chlamydia infected trophoblast and a down regulation of HMG-CoA reductase. The levels of 
estrogen and progesterone were decreased, while the expression of aromatase and adrenodoxin reductase was 
up regulated. Also, there was a decrease in human chorionic gonadotropin expression. The implications of these 
findings are that C. trachomatis infection of trophoblast may compromise cellular cholesterol biosynthesis, thus 
depleting the substrate pool for estrogen and progesterone synthesis. This defect may impair trophoblast 
functions of implantation and placentation, and consequently affect pregnancy sequelae. 
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1.  Introduction 
Trophoblast, the first cell to differentiate from the 
fertilized egg is an invasive, eroding and metastasizing 
cell that exhibits a crucial role in implantation and 
placentation [1, 2, 3]. Preceding the invasion event, the 
uterine mucosa is transformed in a process called 
decidualization. It is such suitable environment that 
allows the differentiation of trophoblast in the villous 
and extravillous pathways [4]. The fulfillment of the 
enormous role of ensuring proper implantation and 
placentation requires a number of functional 
characteristics inherent in the trophoblast. These 
functions include; neural and endothelial functions [5, 
6], phospholipids signaling function [7], endocrine 
functions [8], and immunocyte function. It stands to 
reason therefore that trophoblast injury will mediate 
impairment of these functions and degenerate into 
disturbed implantation and placentation [9]. 
Therefore, there is a compelling need to understand 
the role of a potential trophoblast injury mediator, 
such as a prevailing chlamydial infection afflicting the 
reproductive system. It is such need that this research 
addresses. 
Chlamydia trachomatis is of significant importance 
as a cause of human diseases including, trachoma [10], 
infertility [11], salpingitis and ectopic pregnancy [12]. 
Chlamydiae are strict intracellular pathogens that 
exert enormous metabolic pressure on cells. Their life 
cycle is biphasic; the extracellular infectious form is the 
elementary bodies (EBs), which are metabolically inert. 
When they infect susceptible host cells, they transform 
into the reticulate bodies (RBs), which are the 
vegetative form of the organism, capable of metabolic 
activities and replicate intracellularly [13]. 
Pathophysiologic changes resulting from C. trachomatis 
affliction of cells are well documented, and 
importantly,  C. trachomatis is the most prevalent 
bacterial cause of sexually transmitted diseases [14, 
15]. Evidences abound that chlamydiae infection may 
cause human abortion by unknown mechanism [16, 
17].  
I n  t h i s  s t u d y ,  w e  r e a s o n e d  t h a t  c h r o n i c  C. 
trachomatis affliction of the female genitalia which 
ascends into the uterus may be capable of infecting 
cells that mediate important functions throughout 
pregnancy and infflict injuries that could compromise 
their functions. Thus, the underlying hypothesis here 
is;  C. trachomatis infection of trophoblast inflicts 
sufficient injury that impairs trophoblast endocrine 
functions. We have tested this hypothesis by: assessing Int. J. Med. Sci. 2007, 4 
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the status of C. trachomatis infection of trophoblast, 
investigating the impact of productive infection on the 
capacity of trophoblast to synthesize cholesterol (the 
precursor molecule for estrogen and progesterone 
biosynthesis), examining the synthesis of these steroid 
hormones and determined whether infection affected 
the production of human chorionic gonadotropin 
(hCG), which has a regulatory role on early 
trophoblast functions. We report our findings that 
provide mechanistic insights into the way and manner 
in which C. trachomatis inflicts pathologies that affect 
pregnancy outcome.  
2.  Materials and Methods 
Chemicals 
All chemicals and reagents were purchased from 
Sigma Chemical Company (St. Louis, MO) unless 
otherwise stated. 
Trophoblast Culture 
Human trophoblast cell line (JAR) (ATCC, 
Maryland, USA) was grown in RPMI 1640 medium 
with 2mM L-glutamine that is modified to contain 
10mM HEPES, 1mM sodium pyruvate, 4.5g/l glucose, 
1.5g/l bicarbonate (Invitrogen, Life Technologies, 
Carlsbad, CA) supplemented with 10% FBS (Hyclone, 
Logan, Utah, USA), 50μg/ml vancomycin, 10μg/ml 
gentamicin maintained in a 37°C, 5% CO2 humidified 
i n c u b a t o r .  A t  s u b c o n f l u e n c y ,  r e s i d u a l  m e d i u m  w a s  
removed and cells were rinsed free of medium using 
PBS, then 2-3ml of 0.25% (w/v) Trypsin-0.53 mM 
EDTA solution was added to flask and observed for 
cell layer dispersal (usually 5min). Eight milliliter of 
medium was added to flask and cells were mixed by 
gentle pipetting. Appropriate aliquots of cell 
suspension were seeded in new culture vessels or into 
wells for experiments. Cells were tested for 
mycoplasma contamination periodically by staining 
with 4,6 diamine-2-phenyl indole dihydrochloride 
(Boehringer, Mannheim, Germany). 
Chlamydia trachomatis culture 
Chlamydia trachomatis ( D  s e r o v a r )  w a s  o b t a i n e d  
from ATCC and propagated in HEp-2 cell monolayer 
by centrifugation (1864 X g Sorvall RC5C, SH-3000 
rotor) driven infection for 1 hour followed by rocking 
in a humidified incubator at 37°C and 5% CO2 for 1hr 
30min. The residual medium was aspirated and 
r e p l a c e d  w i t h  f r e s h  g r o w t h  m e d i u m  c o n t a i n i n g  F B S  
prescreened for chlamydia antibodies and 2μg/ml 
cycloheximide (cycloheximide was not used in 
instances where chlamydia infection was for 
experimental purposes). It was then returned to the 
humidified incubator at 37°C and 5% CO2 for 72hr. At 
the end of 72hr, C. trachomatis was harvested , 
sonicated, loaded onto discontinuous gradient of 
urografin (Schering, Berlin, Germany), and elementary 
bodies(EBs) were pelleted at 17,211 x g (Sorvall RC5C, 
SS-34 Rotor) for 1hr at 4°C. Harvested EBs were stored 
at -80°C in sucrose phosphate glutamate buffer (0.22M 
sucrose, 10mM sodium diphosphate, 5mM glutamic 
acid, pH 7.4) in small aliquots and thawed as needed 
[18]. C. trachomatis inclusion forming units (IFU) were 
determined by thawing a frozen aliquot of the 
harvested purified EBs and infecting confluent (5x105 
cells/well) HEp-2 cell monolayers in 24 well plate with 
10 fold serial dilution in medium using the 
centrifugation assisted procedure already described. 
Infected cells treated with cycloheximide were 
incubated at 37°C for 72 hours, washed, fixed in 
methanol, and stained using fluorophore labeled 
anti-lipopolysaccharide antibody (chlamydia 
identification kit, Bio-Rad, Woodinville, WA, USA). 
The total inclusion forming units was enumerated by 
counting 10 microscope fields(x 200 magnification) 
using an inverted fluorescent microscope (Olympus, 
Melville, NY, USA) 
Infection of trophoblast with Chlamydia trachomatis 
Trophoblast monolayer was washed with 
phosphate buffered saline (PBS), then infected with 
1ml (6 well plate) of multiplicity of infection (MOI) of 3 
elementary bodies (EBs) per cell. The capacity of C. 
trachomatis to infect trophoblast was assessed using 
similar methods described above for quantification of 
IFU/ml in 24 well plate but in this instance 
photomicrography was recorded and compared with 
records for the infection of HEp-2 cells using EBs from 
stocks in our lab at MOI=3/cell.   
Assessment of Chlamydia trachomatis status in 
trophoblast 
The efficacy of C. trachomatis infection of 
trophoblast was assessed by (i) determining the 
capacity of C. trachomatis to initiate productive and 
transferable infection in trophoblast. This involved the 
time course harvesting and purifying of EBs from 
infected trophoblast and titration onto HEp-2 cell 
monolayer (19). Chlamydial inclusion forming units 
(IFUs) was enumerated and compared with IFUs 
obtained from direct HEp-2 cells infection using EBs 
from our lab stock. In all instances infection was 
established in 25-45% of HEp-2 cells using C. 
trachomatis harvested from infected trophoblast. (ii) 
Also determining the percent infectivity of trophoblast 
by C. trachomatis, by counting cells in ten fields and 
enumerating the numbers of infected trophoblast. The 
time course percent infectivity was recorded and 
compared with time course percent infectivity of 
HEp-2 cells by EBs from lab stock. In some instances 
also, the capacity of C. trachomatis to assume a chronic 
course in trophoblast was assessed using accepted 
molecular indices by assay of chlamydial HSP-60 and 
MOMP protein from C. trachomatis harvested from 
trophoblast.  
Trophoblast cholesterol assay 
Trophoblast cellular cholesterol was estimated 
using fluorimetric procedures described in assay kit 
manual (Amplex Red Cholesterol Assay Kit, Molecular 
probes, Eugene, OR) [20]. Protein estimation [21] was 
also done on lysate. Cholesterol was reported as 
µg/mg protein. Int. J. Med. Sci. 2007, 4 
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Trophoblast estradiol assay 
Trophoblast cellular estradiol was assayed using 
enzyme immunoassay procedures described in assay 
kit manual (Cayman Chemical Company, Ann Arbor, 
MI) [22]. Absorbance was recorded at wavelength of 
415nm using microplate reader (BioRad Microplate 
Reader 3550, Hercules, CA). Protein estimation [21] 
was also done on lysate. Estradiol was reported as 
ng/mg protein. 
Trophoblast progesterone assay 
Trophoblast cellular progesterone was assayed 
using the fluorimetric progesterone receptor 
competitive assay procedure described in the assay kit 
manual (Progesterone Receptor Competitive Assay, 
Green, Invitrogen Corporation, Carlsbad, CA). In the 
test, glutathione transferase anchors human 
progesterone receptor to expose the ligand binding 
sites. A competitive assay is then performed between 
fluormone tagged to progesterone epitope and the free 
progesterone in the sample or standard. Progesterone 
displaces fluormone tagged progesterone causing 
increased fluorescence. Briefly, 50µl of sample or 
standard was put in microtiter plate and 50µl of 
reaction mix (40µl PR LBD progesterone receptor, 10µl 
Fluormone PL Green tagged progesterone ligand, 4µl 
DTT, 946µl PR Screening Buffer Green). Microtiter 
plate was incubated at room temperature while 
rocking for 2h. Fluorescence was recorded at emission 
wavelength of 485nm and an excitation wavelength of 
530nm using CytoFluor 4000 ((Applied Biosciences, 
Woodinville, CA). Protein estimation [21] was also 
done on lysate. Progesterone was reported as mg/mg 
protein. 
Assay of HMG-CoA reductase, aromatase, 
adrenodoxin reductase, cHSP-60, MOMP, and hCG 
protein 
Western blot was run on lysates of uninfected 
trophoblast, or C. trachomatis infected trophoblast, or C. 
trachomatis harvested from trophoblast after time 
course infection. Protein was precipitated with 10% 
trichloroacetic acid and resuspended in assay buffer 
(BioRad Laboratories, CA, USA) [23]. Briefly, 25μg 
protein was spotted per lane on 10% 
SDS-polyacrylamide gel. After electrophoresis, protein 
bands were electrophoretically transferred to 0.2 μM 
Immun-Blot PVDF membrane (BioRad Laboratories, 
CA, USA). To avoid non-specific binding, blocking 
was done with 3% blocker provided with the kit, 
washed and incubated with primary antibodies; 
anti-cHSP-60, or anti-aromatase, or anti-hCG, or 
anti-adrenodoxin-reductase (ABCAM Inc, Cambridge, 
MA), or anti-MOMP (Virostat Inc, Portland ME), or 
anti-HMG-CoA reductase (Upstate Biotechnology, 
Lake Placid, NY), or anti-actin (Santa Cruz Biotech, 
CA) for internal control at dilutions of 1:500 for 1h, 
then washed and incubated with GAx-HRP (horse 
radish peroxidase) (BioRad Laboratories, CA, USA) at 
a dilution of 1:5000 for 1h, then washed with PBST 
buffer [24]. Colorimetric detection was done according 
to manufacturers instructions. Band intensity was 
determined using Gel Logic 200 (Kodak, Chicago, IL) 
Protein Estimation 
Protein assay on each sample was done by the 
bicinchoninic acid-copper (II) sulphate reagent assay 
system [21]. 
Statistical Analysis 
All data are expressed means ± standard error of 
triplicate samples. Data were analyzed by Student’s 
t-test using difference between means of two 
treatments and p values of 0.05 were reported as 
significant. In some instances, the repeated measures 
analysis of variance (ANOVA) model was used for the 
dependent variables.  
3.  Results 
Chlamydia trachomatis induces a productive 
infection in human trophoblast 
Since  C. trachomatis-host interaction and the 
capacity of the resultant infection to impact host cell 
functions are dependent on transferability of infectious 
elementary bodies from cell to cell, we decided to 
investigate if it would initiate a productive infection in 
human trophoblast cell line, thereby providing 
insights into the enormity of chlamydial STD on 
reproductive outcome. Regular C. trachomatis 
inclusions were demonstrable in trophoblast (Fig. 1a), 
although there was significantly reduced inclusion 
formation when compared with results obtained in 
direct infection of HEp-2 cells (Fig. 1b). It is important 
to note that time course percent infectivity of 
trophoblast (direct trophoblast infection) varied from 
25%-45% (Fig. 1d), a significant finding considering the 
nature of trophoblast. To assess the capacity of C. 
trachomatis to initiate productive infection in 
trophoblast, time course harvest of C. trachomatis EBs 
from trophoblast were used to infect HEp-2 cell 
monolayer and results showed that they exhibited 
efficient inclusion forming capability (Fig. 1c, grey 
bars). However, this result was significantly reduced 
(p<0.01) when compared with direct infection of 
HEp-2 cells (conventional cells that permit chlamydia 
growth) using EBs from our laboratory stock at MOI=3 
EBs/cell (Fig. 1c, black bars). It is important to note 
that the data here are comparable to those obtained in 
similar experiments using macrophage cell line [19]. 
Chlamydia trachomatis exhibits increased HSP-60 
shedding during infection of human trophoblast 
In order to evaluate the impact of infection of 
trophoblast on C. trachomatis forms and status, we 
assessed the expression of the molecular determinants 
of chronicity such as heat shock protein-60 (HSP-60) 
protein in relation to major outer membrane protein 
(MOMP) protein. Chlamydia trachomatis exhibited time 
course increase in expression of HSP-60 protein in 
infected trophoblast compared with infected HEp-2 
cells (p<0.05), there was a more significant cHSP-60 
shedding in infected trophoblast at time points after 
72hr (p<0.01) with a decline at 96 h likely due to the Int. J. Med. Sci. 2007, 4 
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effect of the clustering of trophoblast cells which might 
have impacted C. trachomatis propagation (Figs. 2a, 2b). 
It is important to note that experiments were set up 
without cycloheximide (which could annul the 
clustering of trophoblast at appropriate concentration 
– 0.3µg/ml) to avoid possible effect of drug on results. 
The increased expression of HSP-60 is significant, since 
in normal circumstances an increase in MOMP is 
expected with increase in infection forming units 
(IFUs) while HSP-60 level is suppose to be constant 
(see Fig. 2c in the case of HEp-2 cells).  
 
 
 
 
Fig. 1. Induction of productive infection by Chlamydia trachomatis in trophoblast. The formation of Chlamydia trachomatis 
inclusion (MOI = 3/cell) in trophoblast (A) compared with direct infection of HEp-2 cells (B) is represented. Experimental procedure 
was repeated three times. Panel (A) indicates HEp-2 cell infection with Chlamydia trachomatis that has been harvested from 
trophoblast cell line JAR and titrated onto HEp-2 cells. Panel (B) shows a direct infection of HEp-2 cells with Chlamydia 
trachomatis. Notice the relative suppression of Chlamydia trachomatis growth in trophoblast. The arrows indicate Chlamydia 
trachomatis inclusion bodies. However, the Chlamydia trachomatis harvested from trophoblast were able to efficiently infect HEp-2 
cells (productive infection), (C) although there is a significant difference (p < 0.01 *) in IFU/ml when Chlamydia trachomatis 
harvested from trophoblast are compared with regular EBs in our laboratory are used to infect HEp-2 cells (C). Further, percent 
infectivity of HEp-2 cells is shown in (D). There is a significant difference (p < 0.01 *) between direct infection of HEp-2 cells (red) 
and infection of HEp-2 cells with Chlamydia trachomatis harvested from trophoblast. All values represent means ± SEM (n = 3).
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Fig. 2. HSP-60 shedding by Chlamydia trachomatis during 
infection of trophoblast.  The shedding of Chlamydia 
trachomatis HSP-60 compared with MOMP during infection of 
trophoblast is depicted (A). There is time-course increase in 
Chlamydia trachomatis HSP-60 protein (-■-) with a peak at 72 h 
(B) compared with MOMP (-♦-) (p < 0.01 * ). Additionally, 
Chlamydia trachomatis HSP-60 shedding and MOMP 
expression is also shown in direct infection of HEp-2 cells (C). 
HSP-60 expression slowly decreases over time (-▲-), whereas 
MOMP (-x-) expression shows a time-course increase to 84 h 
before declining at 96 h (p < 0.05 *). All values represent means 
± SEM (n = 3). 
Chlamydia trachomatis induces an impairment of 
cholesterol biosynthesis in human trophoblast 
Since trophoblast play important physiologic role 
in the process of steroid hormone regulated 
implantation and placentation during pregnancy, we 
decided to explore the consequence of C. trachomatis 
infection on trophoblast capacity to synthesize 
cholesterol, the precursor of steroid hormones. Figure 
3a shows that after an initial significant up regulation 
of cholesterol (p < 0.01), there was a decline below 
cellular cholesterol levels of uninfected trophoblast at 
84 and 96 h (p<0.06). This modulation of cellular 
cholesterol by infection was further investigated by 
evaluating the effect of this event on the rate limiting 
enzyme of cholesterol biosynthesis, 
3-hydroxy-3-methylglutaryl-Co enzyme-A 
(HMG-CoA) reductase. Infection down regulated the 
expression of HMG-CoA reductase protein expression 
(Figs. 3b and 3c) (p < 0.05).  
 
 
 
Fig. 3. Chlamydia trachomatis induces changes in cholesterol 
biosynthesis.  The levels of cellular cholesterol in infected 
trophoblast (-♦-) compared with uninfected (-■-) trophoblast is 
depicted. There was an initial increase in cholesterol level which 
was significant (p < 0.05 *) and was followed by a decline (A). 
Protein expression (B & C) of HMG-CoA Reductase (the 
rate-limiting enzyme of cholesterol biosynthesis) was decreased 
in infected trophoblasts (-♦-) compared with uninfected 
trophoblasts (-■-) (p < 0.05 *). All values represent means ± 
SEM (n = 3). Int. J. Med. Sci. 2007, 4 
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Fig. 4. Induction of estradiol down-regulation in Chlamydia 
trachomatis infected trophoblast. The cellular estradiol level 
of infected trophoblast (-♦-) compared with uninfected cells 
(-■-) is depicted (A). There was significant decline in estradiol 
production (p < 0.01 * ) in infected trophoblast. The time-course 
level of aromatase production is represented in B & C. There 
was a significant increase in expression of the enzyme (p < 0.05 
*) in infected trophoblast (-♦-) compared with uninfected 
trophoblast (-■-). All values represent means ± SEM (n = 3). 
Chlamydia trachomatis infection of trophoblast 
down regulated estrogen biosynthesis 
The pattern of modulation of trophoblast 
cholesterol biosynthesis suggests a probable 
accompanying interference with steroid hormone 
synthesis. To assess if cholesterol synthesis 
impairment had effect on estrogen production by 
trophoblast infected with C. trachomatis, we estimated 
the cellular estradiol and evaluated the protein of the 
rate limiting enzyme, aromatase. Figure 4a shows a 
significant decline in infected trophoblast estradiol (p 
< 0.01) compared with uninfected trophoblast. 
However, there was an up regulation of aromatase 
protein (Figs. 4b and 4c) (p < 0.05).  
 
 
 
 
 
 
 
Fig. 5. Induction of Progesterone down-regulation in 
Chlamydia trachomatis infected trophoblast. The level of 
progesterone in trophoblast infected with Chlamydia 
trachomatis is shown in A. There was a significant (p < 0.01 *) 
decline in progesterone production in Chlamydia trachomatis 
infected cells (-♦-) compared with uninfected cells (-■-). The 
levels of adrenodoxin reductase are depicted in B & C. There 
was a significant (p  < 0.01 *) up-regulation of enzyme in 
infected cells (-♦-) compared with uninfected cells (-■-). All 
values represent means ± SEM (n = 3). Int. J. Med. Sci. 2007, 4 
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Fig. 6. Down-regulation of hCG in Chlamydia trachomatis 
infected trophoblast. The effect of Chlamydia trachomatis on 
trophoblast hCG production during infection is depicted as hCG 
protein expression (A and B). Panel A shows reduction in 
β-hCG in infected trophoblast compared with uninfected cells. 
Less change was recorded in α-hCG. There was a significant 
decline (p  < 0.05 *) in β-hCG production (B) in infected 
trophoblast (-x-) compared with uninfected (-■-) while the 
α-hCG showed no significant difference when Chlamydia 
trachomatis  infected trophoblast (-▲-) is compared with 
uninfected trophoblast (-♦-). All values represent means ± SEM 
(n = 3). 
 
Trophoblast infected with Chlamydia trachomatis 
showed an impairment of progesterone biosynthesis 
Preceding data indicate a physiologic 
compromise in the synthesis of trophoblast cellular 
cholesterol and an accompanying impact on estradiol; 
therefore we reasoned that additional insights could be 
obtained by investigating the impact of impaired 
trophoblast cholesterol synthesis on progesterone 
production. There was a decrease in cellular 
progesterone in C. trachomatis infected trophoblast 
(Fig. 5a) (p < 0.01). To further investigate what this 
entails in terms of the biosynthesis of progesterone, we 
decided to measure the protein expression of the rate 
limiting enzyme of progesterone biosynthesis, 
adrenodoxin reductase. This finding suggest that there 
was a possible compensatory feedback up regulation 
of adrenodoxin reductase protein (Figs. 5b and 5c), but 
the final effect of depleted cholesterol biosynthesis 
after 72 h may generate an impairment of substrate 
availability for progesterone biosynthesis. 
Defective production of human chorionic 
gonadotropin by Chlamydia trachomatis infected 
trophoblast  
Since the induction of trophoblast function 
during pregnancy depends on human chorionic 
gonadotropin by trophoblast, we decided to assess the 
effect of C. trachomatis infection on hCG production by 
trophoblast. β-Human chorionic gonadotropin protein 
component of hCG was significantly depleted in C. 
trachomatis infected trophoblast (Figs. 6a and 6b) 
compared with uninfected (p < 0.05). The α-hCG 
protein component showed an initial increase 
accompanied by a decline.  
 
 
4.  Discussions 
Mechanistic insights into the ways and manners 
in which C. trachomatis inflict serious diseases, 
especially those affecting pregnancy outcome are 
needed for improved management of female 
reproductive life. Chlamydia trachomatis, like other 
chlamydiae, is known to uniquely take a chronic 
course, an event which is conceivably required for the 
protracted host-pathogen interaction and thus the 
establishment of pathology. Such pathology initiation 
has been associated with inflammatory damages that 
have been consistently correlated with seropositivity 
of chlamydial HSP-60 (cHSP-60) [25], a finding which 
extends to other chlamydia species [24].  
There is compelling molecular evidence provided 
by the data reported here suggesting that C. trachomatis 
may assumes a chronic course in trophoblast (Figs. 2a, 
2b and 2c) alongside with a relative productive 
infection (Fig. 1c, grey bar). Arguably this event is less 
significant compared with direct infection of HEp-2 
cell (Fig. 1c, black bar), which are more conventional 
cells for chlamydia propagation. This finding is 
important. First, trophoblast cells are avidly 
phagocytic and are endowed with the capacity to 
produce reactive nitrogen and oxygen intermediates 
and other lethal biomolecules [26, 27, 28], re-enforcing 
the hypothesis of a protective role for trophoblast 
against infectious agents at the fetal-maternal interface 
[3]. This characteristic of trophoblast should render it 
non-susceptible to C. trachomatis. Despite this feature 
of trophoblast, C. trachomatis is able to colonize it and 
produce transferable infection. Therefore it stands to 
reason that the endowment of trophoblast with 
capacity to evoke such immune defenses may account 
for the differences in infectivity of trophoblast 
compared with HEp-2 cells. Second, the up regulation 
of cHSP-60 shedding, which is suggestive of chronicity 
[29], implies that such infection may not be transient 
and arguably impacts the functional capabilities of 
trophoblast, especially steroid hormone biosynthesis; 
activities that are of tremendous importance for Int. J. Med. Sci. 2007, 4 
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fetal-maternal relation. It is important to note that the 
observations reported here are changes observed in 
infected trophoblast cell line JAR and not primary 
trophoblast cells which may produce different pattern 
of responses following chlamydia infection. The 
possibility of replicating these findings is the basis of 
an on-going in vivo study in our laboratory. 
Chlamydia trachomatis uniquely harbors 
eukaryotic host cell cholesterol in its EBs and 
parasitophorous vacuole membrane, with evidence 
that such biomolecules are trafficked from host system 
[30]. Previous reports [23] have provided compelling 
evidence that in chlamydial infectious course in 
macrophage (forms suggestive of chronicity), the 
impact of cholesterol trafficking from host cell to 
chlamydia results in depleted host cell cholesterol; 
thus starving host cell of cholesterol for other 
requirements such as membrane biosynthesis. We 
report here a finding of an initial increase in 
trophoblast cellular cholesterol with an accompanying 
decline (Fig. 3a), which we reasoned may have 
impacted host cellular biosynthesis of steroid 
hormones (estrogen and progesterone). The levels of 
estrogen and progesterone are critical factors in 
pregnancy sustenance [31]. They enrich the uterus 
with thick lining of blood vessels and capillaries so 
that it can sustain the growth of fetus. We report a 
decline in estrogen and progesterone in chlamydial 
infected trophoblast and an accompanying positive 
feedback up regulation in the rate limiting enzymes in 
the biosynthetic pathways of these hormones. 
However, such up regulation of enzymes did not 
manifest in hormone production because of starvation 
in substrate (cholesterol) levels. This report of 
impaired steroid hormone metabolism is important, 
especially so in view of the fact that invitro studies 
abound demonstrating a correlation between changes 
in steroid hormones metabolism, steroid hormone 
receptor expression and the event of implantation and 
placentation [32]. 
Trophoblast impaired estrogen and progesterone 
production can account for failure of trophoblast 
invasion of the endometrium and has been associated 
with some cases of pre-eclampsia [33, 34, 35]. The 
importance of this finding about compromised 
estrogen and progesterone biosynthesis in C. 
trachomatis infected trophoblast is of enormous 
significance in the face of previous reports of 
unexplainable induction of abortion by chlamydia [17]. 
Human chorionic gonadotropin is not only the 
regulator of trophoblast steroid hormone biosynthesis; 
it also acts synergistically alongside other factors from 
the ovary to establish a receptive endometrium [36]. 
We found a decline in β-hCG protein in infected 
trophoblast (Fig. 6b). The reason for the decline is not 
very clear, however, it is important to note that the 
cysteine requirement of C. trachomatis MOMP is 
enormous and infected trophoblast may have to 
competitively channel cysteine to MOMP and hCG 
(which also has a lot of cysteine amino acid units in its 
β-hCG sequence), thus compromising the level of 
amino acid available. 
This study has provided some mechanistic 
insights into the physiologic change meted on 
trophoblast by C. trachomatis infection which through 
the establishment of chronic onset along with relative 
productive infection depletes cholesterol and hCG 
elaboration. These findings of impaired trophoblast 
functions provide additional details in line those 
reported by Equils et al., 2006 [37], in which cHSP-60 
was used to mediate trophoblast apoptosis. Also, it 
provides further understanding on how C. trachomatis 
plays an etiologic role in pathogenesis of disturbed 
pregnancies, other than the classical explanation of 
possible fibrosis of fallopian tubes and infection of 
newborn. The physiologic events reported in our study 
shows the dynamics of biomolecular trafficking 
between human trophoblast and intracellular C. 
trachomatis, as well as their effects on biosynthetic 
processes and a predictable probable impairment of 
proper pregnancy development.  
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